FDA approves first generic of Novo Nordisk’s Victoza

by
Contributor since / Followers

1 day ago

The U.S. FDA has approved the first generic version of Novo Nordisk’s (NVO) GLP-1 for type 2 diabetes, Victoza (liraglutide).
The approval was granted to Hikma Pharmaceuticals USA.
The agency noted that brand-named Victoza is currently in shortage.
An authorized

Tags: TEVA